HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Schmiedek Selected Research

Nicardipine (Dagan)

12/2011Feasibility of intraventricular nicardipine prolonged release implants in patients following aneurysmal subarachnoid haemorrhage.
11/2011The use of nicardipine prolonged release implants (NPRI) in microsurgical clipping after aneurysmal subarachnoid haemorrhage: comparison with endovascular treatment.
1/2011Nicardipine pellets for the prevention of cerebral vasospasm.
4/2010Correlation of clinical outcome with pressure-, oxygen-, and flow-related indices of cerebrovascular reactivity in patients following aneurysmal SAH.
5/2009Characterization of functional outcome and quality of life following subarachnoid hemorrhage in patients treated with and without nicardipine prolonged-release implants.
2/2007Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter Schmiedek Research Topics

Disease

8Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
01/2012 - 06/2003
7Intracranial Vasospasm
12/2011 - 07/2005
6Glioblastoma (Glioblastoma Multiforme)
01/2019 - 12/2014
5Infarction (Infarctions)
11/2014 - 07/2005
5Aneurysm (Aneurysms)
12/2011 - 06/2003
4Neoplasms (Cancer)
01/2019 - 10/2007
3Ischemia
12/2014 - 10/2007
3Cerebrovascular Disorders (Cerebrovascular Occlusion)
11/2014 - 06/2008
2Wounds and Injuries (Trauma)
01/2019 - 03/2017
2Infections
03/2017 - 12/2014
2Moyamoya Disease (Moya-Moya Disease)
11/2014 - 04/2005
2Intracranial Aneurysm (Cerebral Aneurysm)
10/2007 - 04/2005
1Cysts
01/2019
1Diabetes Mellitus
03/2017
1Fistula
03/2017
1Surgical Wound Infection
03/2017
1Hydrocephalus (Hydrocephaly)
03/2017
1Brain Neoplasms (Brain Tumor)
03/2017
1Necrosis
12/2014
1Hemorrhage
12/2014
1Intraoperative Complications
11/2014
1Anemia
11/2008
1Hypotension (Low Blood Pressure)
11/2008
1Cerebral Infarction
11/2008
1Hypertension (High Blood Pressure)
08/2007
1Spinal Stenosis (Stenosis, Spinal)
08/2005
1Intervertebral Disc Displacement (Herniated Disc)
08/2005
1Pathologic Constriction (Stenosis)
08/2005
1Brain Ischemia (Cerebral Ischemia)
04/2005

Drug/Important Bio-Agent (IBA)

6Nicardipine (Dagan)FDA LinkGeneric
12/2011 - 02/2007
3Temozolomide (Temodar)FDA LinkGeneric
04/2017 - 09/2015
3clazosentanIBA
01/2012 - 07/2005
2ArtesunateIBA
04/2017 - 01/2017
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
06/2008 - 04/2005
1TitaniumIBA
03/2017
1SteroidsIBA
03/2017
1Celecoxib (Celebrex)FDA Link
09/2015
1XenonIBA
11/2014
1MM 36IBA
11/2014
1Acetazolamide (Diamox)FDA LinkGeneric
11/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2009
1Endothelin Receptor AntagonistsIBA
11/2008
1Endothelin A ReceptorIBA
07/2005
1Endothelins (Endothelin)IBA
07/2005

Therapy/Procedure

5Therapeutics
11/2014 - 08/2007
4Radiotherapy
01/2019 - 12/2014
3Chemoradiotherapy
04/2017 - 12/2014
2Drug Therapy (Chemotherapy)
09/2015 - 03/2015
2Cerebral Revascularization
11/2014 - 04/2005
2Surgical Instruments (Clip)
12/2011 - 06/2003
1Combined Modality Therapy
01/2019
1Craniotomy
03/2017
1Catheters
04/2011
1Anesthesia
10/2007
1Hemodilution
08/2007
1Laminectomy
08/2005
1Decompression
08/2005